Nontuberculous Mycobacterial (NTM) Lung Infection is a respiratory condition caused by environmental bacteria found in water and soil. When inhaled, these bacteria can cause serious lung infections, particularly in people with underlying lung conditions or weakened immune systems. Common symptoms include persistent cough, fatigue, shortness of breath, and unexplained weight loss. Unlike tuberculosis, NTM is not contagious between people. Treatment typically involves long-term antibiotic therapy lasting 12 months or more, along with airway clearance techniques. Early diagnosis through CT scans and sputum cultures is crucial for effective treatment and preventing permanent lung damage. While challenging to treat, most patients can successfully manage NTM infections with proper medical care and lifestyle modifications.
Patients are the experts in their condition and advocacy groups provide a platform for patient voices. Working directly with these communities is the key to pushing research forward in an inclusive way.
We’re ready to keep forming links between our Advocacy friends and Pharma partners, so these fruitful relationships continue to evolve beyond the study-to-study view.
Read more...
The ever-growing investment in advocacy doesn’t appear to be slowing down, and research is certainly seeing the benefits. Which at the end of the day, means better patient care and more options for patients.
Read more...
We’ve committed to having 500,000 conversations in the next three years, to equip ourselves and our Pharma partners with the insights needed to increase predictability.
Read more...